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Clinical ResearchAbstract
Introduction: Genetic polymorphisms have been re-
ported to act as modifiers of diverse diseases and, as
such, might theoretically influence the severity and
response to treatment of apical periodontitis. The purpose
of this study was to investigate the association of Fcg
receptor and interleukin (IL)-1 gene polymorphisms with
post-treatment apical periodontitis in Brazilian individuals.
Methods: The study population consisted of 18 patients
with post-treatment apical periodontitis and 44 individ-
ualswith root canal–treated teeth exhibiting healthy/heal-
ing periradicular tissues (controls). Patients were typed for
the following genes (alleles): FcgRIIA (R131 or H131),
FcgRIIIB (NA1 or NA2), IL-1A (1 or 2), and IL-1B (1 or 2).
Results: No significant statistical differences were
observed for all specific genotypes and almost all allele
carriage rates of the test genes as well as combinations
thereof with regard to association with disease (P >
.05). Actually, only 2 genetic conditions were found to
be associated with post-treatment apical periodontitis:
carriage of allele H131 of the FcgRIIa gene (P = .04)
and a combination of this allele with allele NA2 of the
FcgRIIIb gene (P < .01). Conclusions: Data from the
present study suggest that some conditions associated
with polymorphism of Fcg receptor genes might influence
the patient’s response to endodontic treatment of teeth
with apical periodontitis. (J Endod 2009;35:1186–1192)
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1186 Siqueira Jr. et al.Post-treatment apical periodontitis is caused by microorganisms involved in persis-tent or secondary intraradicular infections or in extraradicular infections (1).
Although it is widely recognized that emergence or persistence of post-treatment disease
is dependent on infection (2), the possibility exists that other factors might influence the
development, severity, or response to treatment of apical periodontitis lesions. These
factors are usually known as disease modifiers or susceptibility/severity factors (3, 4).
Interindividual variations in the response to infection might be caused by systemic
conditions or the genetic background of the individual. For instance, diabetes has been
demonstrated to influence the development, course, and healing of apical periodontitis
(5, 6). As for the genetic influence, gene polymorphism has been demonstrated to result
in differences in the expression of molecules involved in inflammation and cellular acti-
vation (4). Existence of genetic polymorphisms might help explain the different courses
of the same disease and the different responses to treatment in different patients (7).
Genetic polymorphisms are recognized when different alleles of a gene are found in
the population. In a biallelic locus, the most common allele is termed normal (N-allele
or allele 1) and must occur in <99%, whereas the rarer allele (R-allele or allele 2) is
present in >1% in the population. The simplest type of polymorphism involves a change
from one nucleotide to another and is referred to as single nucleotide polymorphism
(SNP). Occurrence of SNP within the coding region of a gene might result in production
of an altered protein, whichmight present altered function. Occurrence of SNPwithin the
promoter region of the gene might alter gene regulation. This might lead to reduction/
inhibition of gene expression or, conversely, overexpression of the gene (8). If the
product of the polymorphic gene relates to inflammation or repair, the response might
vary among individuals presenting different genotypes and carrying specific alleles.
FcgR are surface receptors expressed by leukocytes for the constant (Fc) region
of immunoglobulin G (IgG) (9). IgG binds bacteria or bacterial soluble products and
acts as opsonins, favoring the phagocytosis via FcgR by neutrophils or internalization by
antigen-presenting cells, including macrophages and B cells. T cells and natural killer
cells might also become activated when their FcgRs bind IgG-opsonized bacteria (9).
As a consequence of the interaction between IgG-opsonized bacteria and FcgRs on
immune cells, proinflammatory cytokines can be produced and released (9). Polymor-
phisms in the FcgR genes might lead to enhancement or inhibition of events mediated
by FcgR and consequently might influence the susceptibility/severity to inflammatory
diseases. The FcgR genes are found on chromosome 1 and encode 3 main classes
of receptors: FcgRI (CD64), FcgRII (CD32), and FcgRIII (CD16). These classes
are subdivided into the following subclasses: FcgRIa and b, FcgRIIa, b, and c, and
FcgRIIIa and b. Polymorphism in the FcgRIIa gene (or FcgRIIA) is characterized
by a G to A transition that leads to the substitution of histidine (H) (N-allele) for arginine
(R) (R-allele) at amino acid position 131 of the receptor. The FcgRIIA-H131 allotype
binds IgG2 immune complexes efficiently, whereas the FcgRIIA-R131 allotype cannot
mediate this interaction (10). The FcgRIIIb gene (or FcgRIIIB) polymorphism is
caused by 4 amino acid substitutions, which cause differences in receptor glycosylation
with resulting effects on receptor affinity. Polymorphism in the FcgRIIIb gene results in
the FcgRIIIB-neutrophil antigens NA1 (N-allele) or NA2 (R-allele). The FcgRIIIB-NA1
allotype promotes phagocytosis of IgG1- and IgG3-opsonized bacteria or bacterial
products and binds IgG3 complexed to antigens more efficiently than FcgRIIIB-NA2
(9). Studies have found associations between polymorphisms in FcgRIIA and FcgRIIIB
and the severity of periodontal diseases (11–15).
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IL-1a and IL-1b are key cytokines involved with mediation of
inflammation and bone resorption (7, 16). High levels of these cyto-
kines have been demonstrated in apical periodontitis lesions, and
a role in the immunopathogenesis of the disease has been ascribed
(17–20). The genes encoding IL-1a and IL-1b (IL-1A and IL-1B,
respectively) are located in close proximity on the long arm of chromo-
some 2. A biallelic polymorphism of the IL-1B gene at position +3954
(C/T, formerly +3953) was found to result in production of greater
amounts of this cytokine by monocytes (21). Actually, homozygous
individuals for the allele 2 (T) and heterozygous individuals (alleles
1 and 2) might produce, respectively, 4-fold and about 2-fold more
IL-1b than individuals homozygous for allele 1 (C) (21). It has also
been shown that the carriage of allele 2 of IL-1A –889 was associated
with an almost 4-fold increase in the levels of this cytokine (22). Korn-
man et al (23) were the first to report on the role of IL-1 polymorphisms
as a severity factor of marginal periodontitis. The combined presence of
the R-allele of IL-1A at position –889 (within the promoter region) and
the R-allele of IL-1B at position +3954 (within exon 5) was associated
with severity of periodontitis in nonsmoking white patients (23). This
combined carriage rate of the R-alleles of both IL-1A and IL-1B was
designated the IL-1 composite genotype (23). Other investigators
have reported similar findings in cross-sectional studies (24–26).
Apical periodontitis is primarily caused by bacteria, but potential
disease modifiers, such as diabetes, acquired factors, and certain
genetic polymorphisms, might alter the host defense to infection. So
far in endodontic research, only one study has evaluated the influence
of genetic polymorphism on the development of symptomatic infections
(27), and a series of abstracts have been published on the association of
SNP in some cytokine genes with treatment outcome (28–30). Given the
scarcity of data reporting on the association of gene polymorphisms
with endodontic inflammatory diseases, this study investigated the rela-
tionship between FcgRIIA, FcgRIIIB, IL-1A, and IL-1B genotypes and
allele carriage rates and the occurrence of post-treatment disease in
a Brazilian population.
Material and Methods
Individuals and Inclusion Criteria
The protocol for this study was approved by the Ethics Committee
of the Esta´cio de Sa´ University. The population sample that met the inclu-
sion criteria described below involved 62 adult individuals, 37 female
and 25 male, from the cities of Rio de Janeiro, RJ, and Juiz de Fora,
MG, both in the southeastern region of Brazil. A questionnaire was given
to all individuals participating in the study to obtain information
regarding their general health and habits.
Treatment outcome was determined on the basis of radiographic
and clinical evaluations. Immediate postoperative radiographs at the
time of treatment available in the Dental School records and follow-
up radiographs of treated teeth were taken by using film holders, and
treatment outcome was categorized as previously reported (31):
(1) Healed: Contour and width of the periodontal ligament space
(PDL) were normal, or PDL contour was widened mainly around
excess filling. Appearance of surrounding bone was normal.
(2) Healing: Periradicular radiolucency was clearly decreasing in size.
These teeth were included in controls, because a significant level of
healing was observed. Cases with uncertain healing were excluded.
(3) Not healed: Periradicular radiolucency was unchanged or
increased in size.
In teeth with more than 1 root, the least favorable outcome was
registered. Two experienced endodontists who had not been involved
in the treatment or follow-up appointments analyzed independentlyJOE — Volume 35, Number 9, September 2009the radiographs under magnification. In the only 2 cases in which
disagreement occurred, a third observer was consulted. Observers
were calibrated against a set of 100 reference teeth. Clinical examination
was also performed to check for other signs/symptoms of treatment
failure, ie, pain, swelling, or sinus tracts.
Rigid inclusion criteria were used to select patients adequate for
the study purpose. To be enrolled, each individual should have only
1 root canal–treated tooth or more than 1 treated teeth with the very
same periradicular status at the follow-up examination (ie, healthy/
healing or diseased). All individuals should have presented with pulp
necrosis and apical periodontitis at the time of treatment, which in
turn should have been concluded for at least 1 year. Treated teeth
should have both adequate root canal fillings and adequate coronal
restorations. Root canal treatment was ranked as adequate when all
canals were obturated, no voids were present, and fillings ended
from 0–2 mm short of the radiographic apex. A coronal restoration
was ranked as adequate when it appeared clinically and radiographi-
cally intact. Inadequate root canal treatment displayed fillings ending
more than 2 mm short of the radiographic apex or grossly overfilled
and/or with voids, inadequate density, unfilled canals, or poor conden-
sation. Inadequate restoration was any permanent restoration with
detectable radiographic signs of overhangs, open margins or recurrent
caries, or presence of temporary coronal restoration. Teeth with inad-
equate treatment and/or inadequate coronal restoration were excluded
from the study. Teeth with no coronal restorations, permanent or
temporary, were also excluded. Because these rigid inclusion criteria
significantly reduced the number of patients for the post-treatment
group, individuals were recruited from 4 teaching institutions. All of
them were treated either by graduate students or by specialists.
Following these inclusion criteria, the group of post-treatment
disease was composed of 18 patients, whereas 44 individuals with
root canal–treated teeth evincing healthy/healing periradicular tissues
were included as controls.
Sample Taking and DNA Extraction
Sampling and DNA extraction procedures were performed accord-
ing to Laine et al (32). Briefly, each individual rinsed out his/her mouth
with 10 mL of sterile 0.9% saline solution for 1 minute. Samples were
stored frozen at –20C until DNA extraction procedures. For DNA
extraction, samples were thawed at 37C for 10 minutes, and buccal
epithelial cells were centrifuged at 300g for 10 minutes. The pellet
was washed twice in Tris–ethylenediaminetetraacetic acid (EDTA)
buffer (10 mmol/L Tris-HCl, 1 mmol/L EDTA, pH 7.6), resuspended
in 100 mL of 50 mmol/L NaOH, and boiled for 10 minutes. Samples
were neutralized with 14 mL of 1 mol/L Tris (pH 7.5) and centrifuged
at 14,000g for 3 minutes. Supernatants were collected and stored at
–20C until analysis.
FcgRIIA Genotyping
FcgRIIA–R131/H131 genotyping was performed as described
elsewhere (14, 33). Aliquots of 10 mL of DNA extract was added to
50 mL polymerase chain reaction (PCR) mixture containing 5 mL of
10  PCR buffer (Fermentas, Burlington, Canada), 1 mmol/L each
of primer P63 (50-CAA GCC TCT GGT CAA GGT C–30) and P52 (50-
GAA GAG CTG CCC ATG CTG–30), 1 U Taq DNA polymerase (Fermen-
tas), 25 mmol/L MgCl2, and 0.2 mmol/L of each deoxyribonucleoside
triphosphate (Biotools, Madrid, Spain). The first PCR conditions were
as follows: 1 cycle at 95C/5 min, 55C/5 min, and 72C/5 min. This
was followed by 35 cycles at 95C/1 min, 55C/1 min, and 72C/2 min,
ending with an extension step at 72C/10 min. One microliter of the
first PCR product was subsequently reamplified by using a combinationGene Polymorphism and Treatment Outcome 1187
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of the common reverse primer P13 (50-CTA GCA GCT CAC CAC TCC TC–
30) and the G-specific forward primer P5G (50-GAA AAT CCC AGA AAT
TTT TCC G–30) or the A-specific forward primer P4A (50-GAA AAT CCC
AGA AAT TTT TCC A–30), both of which are located at the polymorphic
site on exon 4. The reaction mixture was as above, and temperature
conditions for the second PCR were as follows: 95C/5 min followed
by 30 cycles of 95C/15 s, 60C/30 s, and 72C/30 s, with an extension
step at 72C/10 min. PCR reactions yielded a 278 base pair (bp)
product for both FcgRIIA alleles. Thus, 2 separate PCR reactions
were performed for genotyping of each individual.
FcgRIIIB Genotyping
FcgRIIIB–NA1/NA2 genotyping was performed as described by
Haas et al (34). A common reverse primer (50–ATG GAC TTC TAG
CTG CAC–30) was used in association with a NA1-specific forward
primer (50-CAG TGG TTT CAC AAT GTG AA–30), yielding a 141-bp frag-
ment, and a NA2-specific forward primer (50-CAA TGG TAC AGC GTG
CTT–30), generating a 219-bp fragment. Because there was a substantial
difference in length between the NA1-specific and NA2-specific reaction
products, both alleles could be detected in the same duplex PCR reac-
tion. The reaction mixture (50 mL) contained 10 mL of DNA extract, 5
mL of 10  PCR buffer (Fermentas), 0.6 mmol/L of the NA1 and NA2
primers, 1mmol/L of the reverse primer, 1 U TaqDNA polymerase (Fer-
mentas), 25 mmol/L MgCl2, and 0.2 mmol/L of each deoxyribonucleo-
side triphosphate (Biotools). PCR conditions were as follows: 94C/3
min followed by 30 cycles of 94C/1 min, 57C/2 min, and 72C/1
min, and a final extension step at 72C/10 min.
IL-1A (–889) Genotyping
Primers used for IL-1A (–889) genotyping were IL-1Af (50–AAG
CTT GTT CTA CCA CCT GAA CTA GGC-30) and IL-1Ar (50–TTA CAT
ATG AGC CTT CCA TG-30) (23). PCR amplifications were performed in
50mL of reaction mixture containing 5mL of 10 PCR buffer (Fermen-
tas), 0.8mmol/L concentration of each primer, 1.25 U of TaqDNA poly-
merase (Fermentas), 2 mmol/L MgCl2, and 0.2 mmol/L of each
deoxyribonucleoside triphosphate (Biotools). Thermocycling condi-
tions were as follows: 95C/2 min followed by 45 cycles of 94C/1
min, 50C/1 min, 72C/1 min, and final extension at 72C/10 min.
To confirm amplification, 8 mL of each PCR product was electrophor-
esed on a 2% agarose gel in Tris-borate/EDTA buffer. Gels were stained
with ethidium bromide, and DNA was visualized under ultraviolet light.
PCR product was digested at 37C with NcoI (New England Labs,
Ipswich, MA), and the restriction pattern was visualized by electropho-
resis through a 4% agarose gel. NcoI digestion yields 2 fragments of 16
bp and 83 bp in subjects homozygous for allele 1 and a single fragment
of 99 bp in subjects homozygous for allele 2. All 3 fragments are present
in heterozygous individuals.
IL-1B (+3954) Genotyping
Primers used for IL-1B (+3954) genotyping were IL-1Bf (50-CTC
AGG TGT CCT CGA AGA AAT CAA A–30) and IL-1Br (50–GCT TTT TTG
CTG TGA GTC CCG–30)(23). PCR amplifications were performed in
50 mL of reaction mixture containing 5 mL of 10  PCR buffer (Fer-
mentas), 1mmol/L concentration of each primer, 2 U of Taq DNA poly-
merase (Fermentas), 2.5 mmol/L MgCl2, and 0.2 mmol/L of each
deoxyribonucleoside triphosphate (Biotools). Thermocycling condi-
tions were as follows: 2 cycles of 95C/2 min, 67.5C/1 min, and
74C/1 min followed by 35 cycles of 95C/1 min, 67.5C/1 min, and
74C/1 min. Afterwards, 3 cycles of 95C/1 min, 67.5C/1 mm,
and 74C/5 min completed the profile. To confirm amplification,
8 mL of each PCR product was electrophoresed on a 2% agarose gel.1188 Siqueira Jr. et al.PCR products were then digested with TaqI (New England Labs) at
65C and visualized by electrophoresis through a 4% agarose gel. TaqI
digestion yields 2 fragments of 85 bp and 97 bp in subjects homozygous
for allele 1 and a single fragment of 182 bp in subjects homozygous for
allele 2. The 3 fragments are observed in heterozygous individuals.
PCR Controls
To ascertain the availability of human DNA for analysis, aliquots of
5mL of the DNA extracts from clinical samples were subjected to PCR by
using primers directed to the T-cell receptor Va22 gene (V22f:50-GAT
TCA GTG ACC CAG ATG GAA GGG–30 and V22r:50-AGC ACA GAA GTA CAC
CGC TGA GTC–30), which amplify a fragment of 270 bp (35). PCR ampli-
fications were performed in 50 mL of reaction mixture containing 5 mL
of 10  PCR buffer (Fermentas), 1 mmol/L concentration of each
primer, 1.25 U of Taq DNA polymerase (Fermentas), 3 mmol/L
MgCl2, and 0.2 mmol/L of each deoxyribonucleoside triphosphate (Bi-
otools). PCR conditions included 94C/5 min followed by 45 cycles of
94C/45 s, 60C/30 s, and 72C/1.5 min, and a final extension step at
72C/10 min.
One negative control consisting of sterile ultrapure water instead of
the sample was included for every 10 samples in all batches of samples
analyzed for each gene tested. To confirm the validity of the methods, 10
samples were genotyped twice for each target gene. The results were
identical. Samples exhibiting negative results after PCR were subjected
to reamplification. Samples yielding 3 consecutive negative PCR results
for a given gene were excluded from the respective analysis.
Statistical Analysis
The data concerning distributions for alleles and genotypes
between disease (treated teeth with apical periodontitis) and control
(healthy/healing treated teeth) groups were statistically analyzed by
means of the Pearson c2 test (3  2 contingency tables for specific
genotype frequencies and 2 2 contingency tables for allele frequen-
cies) or the Fisher two-tailed exact test; the latter was used when at least
1 cell of the 2 2 contingency table had a value less than 5. Composite
IL-1 or FcgR genotypes were also evaluated as to the association with
disease. All possible combinations involving alleles and genotypes of
IL-1 or FcgR genes were evaluated. Associations of different character-
istics of the study population with disease or different genetic patterns
were also evaluated by the c2 test or the Fisher exact test. Age was
checked for association with treatment outcome by means of the
Student t test. Significance level was set at P <.05.
Results
Study Population Characteristics
Table 1 depicts the characteristics of the study individuals and
their relationship with health or disease. Diabetes (4 individuals) was
the only systemic condition and smoking (10 individuals) the only
acquired habit reported by the patients that were judged to be potential
disease modifiers and were thereby included as covariates. Both factors
were significantly associated with disease, but none of them showed
a positive relationship with any genotype or allele carriage rate. Sex,
age, and race had no significant influence on treatment outcome.
Fcg Receptor Genotypes
The results of genotyping of the FcgRIIA and FcgRIIIB polymor-
phisms for the individuals with post-treatment apical periodontitis and
controls are displayed in Table 2. Overall, the most prevalent alleles in
the study population were FcgRIIA-H131 (51.6%) and FcgRIIIB-NA2
(84.5%). The genotypes H/H131 and NA2/NA2 were the most common
among the population, occurring in 39.3% and 77.6% of theJOE— Volume 35, Number 9, September 2009
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between any specific genotype of FcgRIIA (P = .12) or FcgRIIIB (P
= .31) and post-treatment disease. However, individuals carrying the
allele FcgRIIA-H131 (R/H131 or H/H131) were significantly more
frequent in the disease group (83%) than in the control group
(56%) (P = .04, Fisher exact test). Although frequencies for allele
FcgRIIIB-NA2 carriage were higher in patients (90.6%) than in
controls (82.1%), this difference was not significant (P = .4, Fisher
exact test). No other significant associations were found for carriage
of the other alleles from either FcgRIIA or FcgRIIIB (P > .05).
Table 3 presents the data on distribution of FcgRIIA and FCgRIIIB
genotype combinations in patients and controls. All possible genotype
combinations disclosed no significant association with disease
(P = .2). However, individuals carrying both allele H131 and allele
NA2 were highly associated with disease (87.5% of patients and 49%
of controls; P < .01).
IL-1 Genotypes
Table 4 presents the allele carriage rates and genotype frequencies
for IL-1A and IL-1B genes in individuals with post-treatment apical
TABLE 1. Characteristics of Study Subjects with Treated Root Canals Associated
or Not with Apical Periodontitis
Characteristic
Patients
with
disease
n (%)
Patients
with
no disease
n (%)
P
value
Gender
Female 9 (24.3) 28 (75.7) .479*
Male 9 (36.0) 16 (64.0)
Race
White 13 (27.7) 34 (72.3) .924*
African-Brazilian 5 (33.3) 10 (66.7)
Systemic condition
Diabetic 4 (100) 0 (0) .005**
Nondiabetic 14 (24.1) 44 (75.9)
Habits
Smoker 7 (70) 3 (30) .004**
Nonsmoker 11 (21.2) 41 (78.4)
Age (y)# 44.9 (14.1) 40.8 (18.4) .394***
*c2.
**Fisher exact test.
***Student t test for independent samples.
#Mean ( standard deviation).
TABLE 2. Distribution of FcgRIIA and FCgRIIIB Genotypes and Alleles in
Subjects with Treated Root Canals Associated or Not with Apical Periodontitis
Patients
with disease
Patients with
no disease Total
Genotype N % N % N %
FcgRIIA 18 43 61
R/R 3 16.7 19 44.2 22 36.1
R/H 6 33.3 9 20.9 15 24.6
H/H 9 50 15 34.9 24 39.3
Allele 36 86 122
R131 12 33.3 47 54.7 59 48.4
H131 24 66.7 39 45.3 63 51.6
FCgRIIIB 16 42 58
NA1/NA1 0 0 5 11.9 5 8.6
NA1/NA2 3 18.8 5 11.9 8 13.8
NA2/NA2 13 81.3 32 76.2 45 77.6
Allele 32 84 116
NA1 3 9.4 15 17.9 18 15.5
NA2 29 90.6 69 82.1 98 84.5JOE — Volume 35, Number 9, September 2009periodontitis and healthy controls. The N-alleles (allele 1) for both genes
were the most frequent, ie, IL-1A-allele 1 was found in 69.3%, and
IL-1B-allele 1 was detected in 74.1% of the population. For both genes,
the carriage rate of allele 1 was always higher in diseased than
in healthy/healing individuals, but significance was not observed
(P = .71 for IL-1A; P = 1 for IL-1B, Fisher exact test).
The homozygous for allele 1 was the most frequently observed
genotype for both IL-1A (56.1%) and IL-1B (60.7%). No significant
associations were found between the different genotypes of IL-1A
(P = .36) or IL-1B (P = .33) and post-treatment apical periodontitis.
No possible genotype combinations of IL-1A and IL-1B exhibited signif-
icant association with disease (P = .43). Individuals presenting the
composite genotype comprising allele 2 of the IL-1A –889 polymor-
phism and allele 2 of the IL-1B +3954 polymorphism were not linked
to disease (P = .47) (Table 5).
Discussion
A myriad of genes are undoubtedly involved in host defenses
against infection, and a challenging task would be to define which
ones display specific variations that predispose to disease and/or influ-
ence disease severity and response to treatment. In the present study, we
evaluated gene polymorphisms that have been regarded as suscepti-
bility/severity factors associated with several human diseases. Individ-
uals with apparently well-treated root canals associated with
periradicular bone destruction (patients) or healthy/healing periradic-
ular tissues (controls) were genotyped for Fcg receptor and IL-1 genes
in an attempt to verify the influence of polymorphisms in these host
defense–related genes on treatment outcome.
The most prevalent alleles detected in this Brazilian subpopulation
were FcgRIIA-H131 (51.6%), FcgRIIIB-NA2 (84.5%), and allele 1
TABLE 3. Distribution of FcgRIIA and FCgRIIIB Genotype Combinations in
Subjects with Treated Root Canals Associated or Not with Apical Periodontitis
Patients with disease
Patients with
no disease
R/R R/H H/H R/R R/H H/H
NA1/NA1 0 0 0 3 2 0
NA1/NA2 0 1 2 3 0 2
NA2/NA2 2 5 6 13 7 11
TABLE 4. Distribution of IL-1A–889 and IL-1B + 3954 Genotypes and Alleles
in Subjects with Treated Root Canals Associated or Not with Apical
Periodontitis
Patients
with disease
Patients with
no disease Total
Genotype N % N % N %
IL-1A –889 17 40 57
1-1 12 70.6 20 50 32 56.1
1-2 3 17.6 12 30 15 26.3
2-2 2 11.8 8 20 10 17.5
Allele 34 80 114
1 27 79.4 52 65 79 69.3
2 7 20.6 28 35 35 30.7
IL-1B +3954 16 40 56
1-1 12 75 22 55 34 60.7
1-2 2 12.5 13 32.5 15 26.8
2-2 2 12.5 5 12.5 7 12.5
Allele 32 80 112
1 26 81.3 57 71.3 83 74.1
2 6 18.8 23 28.8 29 25.9Gene Polymorphism and Treatment Outcome 1189
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reports for other populations (14, 35–38), although prevalence values
and most frequent genotypes might vary significantly according to
geographic location (3). Indeed, the prevalence of Fcg receptor and
IL-1 genotypes might vary significantly among individuals from different
ethnic backgrounds, which makes comparisons among studies very
difficult. Curiously, the homozygous for these alleles were also the
most frequent genotypes in the overall population. This was also true
when individuals were separated into patients (diseased) and controls
(healthy/healing), except for the fact that homozygous for the genotype
FcgRIIA-R131 were more prevalent in controls.
Regardless of the target gene polymorphism, none of the 3 specific
genotypes (homozygous for the N-allele or the R-allele and heterozy-
gous) were associated with post-treatment disease. In fact, only 2 situ-
ations were found to be associated with post-treatment apical
periodontitis: carriage of the allele H131 of the FcgRIIa gene and
a composite genotype consisting of FcgRIIA-H131 and FcgRIIIB-NA2.
Antibodies play an important role in promoting bacterial elimina-
tion, which involves specific binding on the bacterial cell surface
through the antibody Fab portion and then binding to surface receptors
on phagocytes through the antibody Fc portion. How well the antibody
binds to bacteria and receptors on phagocytes will determine its efficacy
and the resulting host response to infection (39). A number of studies
have associated polymorphisms in Fcg receptor genes with a variety of
inflammatory and infectious diseases, such as meningococcal and
pneumococcal infections, rheumatoid arthritis, systemic lupus erythe-
matosus, and periodontal diseases (9, 15, 40–42). In the present study,
we found an association between individuals carrying the FcgRIIA-
H131 allele and post-treatment apical periodontitis. These findings rela-
tively agree with others from the periodontal literature (13, 14). Loos
et al (13) reported that the N-allele (H131) carriage rate was higher
in aggressive periodontitis individuals than in controls, and that perio-
dontitis patients (aggressive and chronic periodontitis) homozygous for
the N-allele (H/H131 genotype) have more periodontal bone loss than
individuals carrying 1 or 2 R-alleles. The increased carriage rate of the
allele FcgRIIA-H131 and the increased prevalence of the FcgRIIA-H/
H131 genotype in aggressive periodontitis suggest a role for this allele
as putative susceptibility/severity factor for this disease. Similarly, Yama-
moto et al (14) reported that individuals exhibiting the FcgRIIA-H/
H131 genotype were more prevalent in the periodontitis group than
in healthy controls.
These results related to both marginal and apical periodontitis are
quite interesting, because FcgRIIA-H131 is the normal (or high affinity)
allele for this gene. For the most part, the rare allele is the one usually
considered as ‘‘poor’’ polymorphism and, as such, is expected to be
associated with disease (36). Polymorphonuclear leukocytes with the
H/H131 genotype bind efficiently to IgG2 and exhibit higher phagocytic
competence than polymorphonuclear leukocytes expressing the
R/R131 genotype (9, 40). Actually, it has been proposed that the
high affinity of FcgRIIA-H131 might contribute to a strong proinflam-
TABLE 5. Frequency of Composite IL-1A2/IL-1B2 Genotype in Patients with
Treated Root Canals Associated or Not with Apical Periodontitis
Patients
with disease
Patients with
no disease Total
Genotype N % N % N %
Positive* 2 13.3 10 27.8 12 23.5
Negative** 13 86.7 26 72.2 39 76.5
*Carrying both alleles 2 of IL-1A and IL-1B.
**Not carrying both alleles 2 of IL-1A and IL-1B.1190 Siqueira Jr. et al.matory cytokine release by monocytes/macrophages on interaction
with IgG, possibly leading to an increased risk for chronic marginal pe-
riodontitis (14). The same theory might be applicable to post-treatment
apical periodontitis.
Although some studies have found the FcgRIIIB-NA2 allele asso-
ciated with some forms of marginal periodontitis (11, 15, 42), this was
not observed in the present study for post-treatment apical periodonti-
tis. Because FcgRIIa and FcgRIIIb receptors have been reported to act
synergistically in triggering neutrophils (40), we decided to investigate
the association of combinations of genotypes and alleles of the 2 recep-
tors with disease. Our findings revealed that the combined carriage of
alleles FcgRIIA-H131 and FcgRIIIB-NA2 was highly associated with
post-treatment apical periodontitis. Other studies in the periodontal
literature have also reported that some composite genotypes of Fcg
receptor genes might be severity factors for marginal periodontitis
(12, 15). The combined carriage of FcgRIIIB-NA2 allele with
FcgRIIIA-V158 allele was strongly associated with severe periodontitis
(12). A significantly higher frequency of the FcgRIIA-H/H131 plus
FcgRIIIB-NA2/NA2 composite in generalized aggressive periodontitis
patients than in healthy controls has also been reported (15). The latter
findings are somewhat in agreement with ours and suggest that
composite genotypes involving alleles H131 from the FcgRIIa gene
and NA2 from the FcgRIIIb gene might have biologic importance to
the point of influencing disease susceptibility, severity, or response to
treatment.
In the present study, the allele carriage rates and genotype
frequencies for IL-1A and IL-1B were not different between diseased
and healthy/healing groups. The same was true for the IL-1 composite
genotype, characterized by combined carriage of the R-alleles of IL-1A
–889 and IL-1B +3954, which has been associated with the severity of
marginal periodontitis (23). A series of studies published so far only as
abstracts revealed that IL-1B polymorphism might influence the
response to endodontic treatment, because individuals homozygous
for the IL-1B-allele 2 were significantly associated with post-treatment
disease (28, 30). The same was not observed for tumor necrosis
factor–b and IL-6 (29, 30). Several studies have also reported on the
association of IL-1 gene polymorphism with a higher severity of peri-
odontal diseases (23, 25, 26, 43), but there are also studies that failed
to confirm such association (37, 44–46). Similarly, our findings do not
confirm those from the early post-treatment apical periodontitis studies
(28, 30), although deeper comparisons cannot be performed because
those are available only as abstracts and only IL-1B polymorphism was
evaluated. Even so, differences might be expected when comparisons
are made between studies with small sample size in different ethnic
groups from different geographic locations. Further studies are needed
to address this issue.
Because of the need to include only teeth with root canal treat-
ments that followed acceptable standards, studies evaluating the caus-
ative agents and susceptibility/severity factors of post-treatment apical
periodontitis are usually plagued by a small sample size. In this regard,
the present study was not an exception. Moreover, the fact that samples
were taken per individual and not per tooth contributed still more to
difficulties in selecting an adequate representative population sample.
This is because a given individual with opposite periradicular condi-
tions in his/her mouth (eg, one adequate treatment associated with
health and another with disease) had to be excluded from the study.
Therefore, although the inclusion criteria related to quality of treatment
and periradicular status were rigid enough to increase the reliability of
our results, the tradeoff was a resultant low sample size, decreasing
statistics power. Another limitation of the present study was the utiliza-
tion of radiographs to establish absence of disease, although radio-
graphs at the time of treatment were available, and in the worst caseJOE— Volume 35, Number 9, September 2009
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scenario teeth classified as healthy might have been healing. This was
not expected to affect the analysis significantly because both healthy
and healing individuals were included in the same group (control).
All the individuals participating in the present study pertained to
the same geographic area (Brazil southeastern region) and socioeco-
nomic status (low or middle low). Age was relatively well-balanced
between diseased patients and healthy/healing controls and along
with gender and race had neither significant influence on the outcome
nor significant association with any individual genetic pattern. Although
ethnicity is an important variable in studies of this nature, it must be
realized that the great difficulties in classifying Brazilian individuals
by color and race as a result of a high racial miscegenation of the pop-
ulation (47) make any comparisons in this regard unreliable. Diabetes
could be a confounding factor, because it has also been suggested to be
a disease modifier (5, 6). However, diabetic individuals were not
excluded from the study because they were in reduced numbers (4 indi-
viduals, all in the disease group). Although they were positively associ-
ated with disease, in spite of being in very low numbers for a reliable
statistic conclusion, diabetics were not found to influence the results
significantly because they were not associated with any specific genotype
or allele. Similar results and the same arguments are applicable to
smokers, for whom previous reports on association with disease
have been conflicting (48–51). Maintenance of diabetics and smokers
in the study was then justified by the difficulties to select individuals who
met our rigid inclusion criteria and because these conditions were not
significantly associated with any specific genetic pattern.
Although the influence of genetic polymorphism on treatment
outcome might be suggested, it would appear too simplistic to attribute
the cause of post-treatment apical periodontitis to an immunologic
failure. Apical periodontitis is apparently a complex disease, in which
microorganisms play a major role as causative factors. Genetic poly-
morphisms, possibly involving multiple genes, can be regarded as
disease modifiers, which can influence severity and/or response to
treatment, but not probably to the point of being responsible for treat-
ment failure. Because this is a very incipient area in endodontic
research, further cross-sectional or case-control studies are required
to confirm or refute our findings and evaluate the association of other
gene polymorphisms with post-treatment diseases. Afterwards, as puta-
tive susceptibility/severity factors are identified, their role as genetic
markers influencing the treatment outcome can then be confirmed
by longitudinal studies. Because the carriage rate of polymorphic alleles
might vary substantially between different ethnic groups, validity of
certain genetic markers as predictors of treatment outcome might
need to be tested for different populations.
In conclusion, the current study of relatively small sample size
suggests that the FcgRIIA-H131 allele carriage and a combination of
this allele with the FcgRIIIB-NA2 allele might be putative susceptibility
or severity factors influencing the outcome of the endodontic treatment
in Brazilians. No other associations were observed for FcgR and IL-1
genotypes or alleles and post-treatment apical periodontitis. Further
studies are needed involving a larger sample size from different
geographic populations to corroborate the present findings. If they
are confirmed, future studies focusing on deciphering the role of the
Fcg receptors in the pathogenesis of post-treatment apical periodontitis
are required.
Acknowledgments
This study was supported by grants from Conselho Nacional de
Desenvolvimento Cientı´fico e Tecnolo´gico (CNPq) and Fundac¸a˜o
Carlos Chagas Filho de Amparo a` Pesquisa do Estado do Rio de
Janeiro (FAPERJ), Brazilian Governmental Institutions.JOE — Volume 35, Number 9, September 2009References
1. Siqueira JF Jr. Aetiology of root canal treatment failure: why well-treated teeth can
fail. Int Endod J 2001;34:1–10.
2. Siqueira JF Jr, Roˆc¸as IN. Clinical implications and microbiology of bacterial persis-
tence after treatment procedures. J Endod 2008;34:1291–301, e3.
3. Loos BG, John RP, Laine ML. Identification of genetic risk factors for periodon-
titis and possible mechanisms of action. J Clin Periodontol 2005;32(Suppl 6):
159–79.
4. Kornman KS. Genetics and periodontal diseases. In: Wilson TG Jr, Kornman KS, eds.
Fundamentals of periodontics. 2nd ed. Chicago: Quintessence Publishing Co; 2003:
171–84.
5. Fouad AF, Burleson J. The effect of diabetes mellitus on endodontic treatment
outcome: data from an electronic patient record. J Am Dent Assoc 2003;134:43–51.
6. Armada-Dias L, Breda J, Provenzano JC, et al. Development of periradicular lesions
in normal and diabetic rats. J Appl Oral Sci 2006;14:371–5.
7. Fouad AF, Huang GT. Inflammation and immunological responses. In: Ingle J,
Bakland LK, Baumgartner JC, eds. Ingle´s endodontics Hamilton. 6th ed. Ontario:
Canada; BC Decker Inc, 2008:343–75.
8. Schork NJ, Fallin D, Lanchbury JS. Single nucleotide polymorphisms and the future
of genetic epidemiology. Clin Genet 2000;58:250–64.
9. van Sorge NM, van der Pol WL, van de Winkel JG. FcgammaR polymorphisms: impli-
cations for function, disease susceptibility and immunotherapy. Tissue Antigens
2003;61:189–202.
10. Warmerdam PA, van de Winkel JG, Vlug A, Westerdaal NA, Capel PJ. A single amino
acid in the second Ig-like domain of the human Fc gamma receptor II is critical for
human IgG2 binding. J Immunol 1991;147:1338–43.
11. Kobayashi T, Westerdaal NA, Miyazaki A, et al. Relevance of immunoglobulin G Fc
receptor polymorphism to recurrence of adult periodontitis in Japanese patients.
Infect Immun 1997;65:3556–60.
12. Kobayashi T, Yamamoto K, Sugita N, et al. The Fc gamma receptor genotype as
a severity factor for chronic periodontitis in Japanese patients. J Periodontol
2001;72:1324–31.
13. Loos BG, Leppers-Van de Straat FG, Van de Winkel JG, Van der Velden U. Fcgamma
receptor polymorphisms in relation to periodontitis. J Clin Periodontol 2003;30:
595–602.
14. Yamamoto K, Kobayashi T, Grossi S, et al. Association of Fcgamma receptor IIa
genotype with chronic periodontitis in Caucasians. J Periodontol 2004;75:
517–22.
15. de Souza RC, Colombo AP. Distribution of FcgammaRIIa and FcgammaRIIIb geno-
types in patients with generalized aggressive periodontitis. J Periodontol 2006;77:
1120–8.
16. Stashenko P, Dewhirst FE, Peros WJ, Kent RL, Ago JM. Synergistic interactions
between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resorption.
J Immunol 1987;138:1464–8.
17. Lim GC, Torabinejad M, Kettering J, Linkhardt TA, Finkelman RD. Interleukin 1-beta
in symptomatic and asymptomatic human periradicular lesions. J Endod 1994;20:
225–7.
18. Barkhordar RA, Hussain MZ, Hayashi C. Detection of interleukin-1 beta in human
periapical lesions. Oral Surg Oral Med Oral Pathol 1992;73:334–6.
19. Martinez ZR, Naruishi K, Yamashiro K, et al. Gene profiles during root canal treat-
ment in experimental rat periapical lesions. J Endod 2007;33:936–43.
20. Wang CY, Stashenko P. The role of interleukin-1 alpha in the pathogenesis of peri-
apical bone destruction in a rat model system. Oral Microbiol Immunol 1993;8:
50–6.
21. Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J. A TaqI polymorphism in the
human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vi-
tro. Eur J Clin Invest 1992;22:396–402.
22. Shirodaria S, Smith J, McKay IJ, Kennett CN, Hughes FJ. Polymorphisms in the IL-1A
gene are correlated with levels of interleukin-1alpha protein in gingival crevicular
fluid of teeth with severe periodontal disease. J Dent Res 2000;79:1864–9.
23. Kornman KS, Crane A, Wang HY, et al. The interleukin-1 genotype as a severity factor
in adult periodontal disease. J Clin Periodontol 1997;24:72–7.
24. McDevitt MJ, Wang HY, Knobelman C, et al. Interleukin-1 genetic association with
periodontitis in clinical practice. J Periodontol 2000;71:156–63.
25. Papapanou PN, Neiderud AM, Sandros J, Dahlen G. Interleukin-1 gene polymor-
phism and periodontal status: a case-control study. J Clin Periodontol 2001;28:
389–96.
26. Lopez NJ, Jara L, Valenzuela CY. Association of interleukin-1 polymorphisms with
periodontal disease. J Periodontol 2005;76:234–43.
27. de Sa AR, Moreira PR, Xavier GM, et al. Association of CD14, IL1B, IL6, IL10 and
TNFA functional gene polymorphisms with symptomatic dental abscesses. Int Endod
J 2007;40:563–72.
28. Morsani JM, Mickel AK, Chogle S, et al. Genetic predisposition to persistent apical
periodontitis. J Endod 2006;32:258.Gene Polymorphism and Treatment Outcome 1191
Clinical Research
29. Kafri D, Mickel AK, Chogle S, Jones JJ, Han Y, Liu H. Role of polymorphism in cytokine
overexpression leading to persistent apical periodontitis. J Endod 2007;33:352.
30. Peritore VA, Mickel AK, Chogle SM, Jones JJ, Han Y. Possible interaction of cytokine
polymorphisms in persistent apical periodontitis. J Endod 2008;34:364.
31. Siqueira JF Jr, Roˆc¸as IN, Riche FN, Provenzano JC. Clinical outcome of the
endodontic treatment of teeth with apical periodontitis using an antimicrobial
protocol. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;106:757–62.
32. Laine ML, Farre MA, Crusius JB, van Winkelhoff AJ, Pena AS. The mouthwash: a non-
invasive sampling method to study cytokine gene polymorphisms. J Periodontol
2000;71:1315–8.
33. Carlsson LE, Santoso S, Baurichter G, et al. Heparin-induced thrombocytopenia: new
insights into the impact of the FcgammaRIIa-R-H131 polymorphism. Blood 1998;
92:1526–31.
34. Haas M, Kleijer M, van Zwieten R, Roos D, von dem Borne AE. Neutrophil Fc gamma
RIIIb deficiency, nature, and clinical consequences: a study of 21 individuals from
14 families. Blood 1995;86:2403–13.
35. Van Den Berg L, Myhr KM, Kluge B, Vedeler CA. Fcgamma receptor polymorphisms
in populations in Ethiopia and Norway. Immunology 2001;104:87–91.
36. Wolf DL, Neiderud AM, Hinckley K, Dahlen G, van de Winkel JG, Papapanou PN.
Fcgamma receptor polymorphisms and periodontal status: a prospective follow-
up study. J Clin Periodontol 2006;33:691–8.
37. Hodge PJ, Riggio MP, Kinane DF. Failure to detect an association with IL1 genotypes
in European Caucasians with generalised early onset periodontitis. J Clin Periodon-
tol 2001;28:430–6.
38. Quappe L, Jara L, Lopez NJ. Association of interleukin-1 polymorphisms with aggres-
sive periodontitis. J Periodontol 2004;75:1509–15.
39. Abbas AK, Lichtman AH, Pillai S. Cellular and molecular immunology. 6th ed. Phil-
adelphia: Saunders/Elsevier; 2007.
40. van der Pol W, van de Winkel JG. IgG receptor polymorphisms: risk factors for
disease. Immunogenetics 1998;48:222–32.1192 Siqueira Jr. et al.41. Kobayashi T, Ito S, Yamamoto K, et al. Risk of periodontitis in systemic lupus eryth-
ematosus is associated with Fcgamma receptor polymorphisms. J Periodontol 2003;
74:378–84.
42. Kobayashi T, Sugita N, van der Pol WL, et al. The Fcgamma receptor genotype as
a risk factor for generalized early-onset periodontitis in Japanese patients. J Perio-
dontol 2000;71:1425–32.
43. Laine ML, Farre MA, Gonzalez G, et al. Polymorphisms of the interleukin-1 gene
family, oral microbial pathogens, and smoking in adult periodontitis. J Dent Res
2001;80:1695–9.
44. Sakellari D, Katsares V, Georgiadou M, Kouvatsi A, Arsenakis M, Konstantinidis A. No
correlation of five gene polymorphisms with periodontal conditions in a Greek pop-
ulation. J Clin Periodontol 2006;33:765–70.
45. Gonzales JR, Michel J, Rodriguez EL, Herrmann JM, Bodeker RH, Meyle J. Compar-
ison of interleukin-1 genotypes in two populations with aggressive periodontitis. Eur
J Oral Sci 2003;111:395–9.
46. Sakellari D, Koukoudetsos S, Arsenakis M, Konstantinidis A. Prevalence of IL-1A
and IL-1B polymorphisms in a Greek population. J Clin Periodontol 2003;30:
35–41.
47. Parra FC, Amado RC, Lambertucci JR, Rocha J, Antunes CM, Pena SD. Color and
genomic ancestry in Brazilians. Proc Natl Acad Sci U S A 2003;100:177–82.
48. Segura-Egea JJ, Jimenez-Pinzon A, Rios-Santos JV, Velasco-Ortega E, Cisneros-
Cabello R, Poyato-Ferrera MM. High prevalence of apical periodontitis amongst
smokers in a sample of Spanish adults. Int Endod J 2008;41:310–6.
49. Bergstrom J, Babcan J, Eliasson S. Tobacco smoking and dental periapical condi-
tion. Eur J Oral Sci 2004;112:115–20.
50. Kirkevang LL, Wenzel A. Risk indicators for apical periodontitis. Community Dent
Oral Epidemiol 2003;31:59–67.
51. Marending M, Peters OA, Zehnder M. Factors affecting the outcome of orthograde
root canal therapy in a general dentistry hospital practice. Oral Surg Oral Med Oral
Pathol Oral Radiol Endod 2005;99:119–24.JOE— Volume 35, Number 9, September 2009
